SER-109 for Recurrent Clostridioides difficile Infection
- PMID: 35584164
- DOI: 10.1056/NEJMc2202493
SER-109 for Recurrent Clostridioides difficile Infection
Comment in
-
SER-109 for Recurrent Clostridioides difficile Infection. Reply.N Engl J Med. 2022 May 19;386(20):1957-1958. doi: 10.1056/NEJMc2202493. N Engl J Med. 2022. PMID: 35584165 No abstract available.
Comment on
-
SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection.N Engl J Med. 2022 Jan 20;386(3):220-229. doi: 10.1056/NEJMoa2106516. N Engl J Med. 2022. PMID: 35045228 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources